Table 3 |
|||||||||
|
Blood glucose, lactate and pyruvate concentrations for each of the three trials. |
|||||||||
|
Blood collection time (min) |
|||||||||
|
Variables |
Trials |
Rest |
15 |
30 |
45 |
60 |
75 |
90 |
End |
|
|
|||||||||
|
[Glucose] (mmol·L-1) |
Control |
4.9 ± 0.9 |
3.8 ± 0.4 |
4.1 ± 0.3 |
4.2 ± 0.4 |
4.0 ± 0.4 |
3.9 ± 0.4 |
3.9 ± 0.5 |
4.1 ± 1.0 |
|
F |
4.7 ± 0.6 |
4.1 ± 0.5 |
4.4 ± 0.4§ |
4.3 ± 0.3 |
4.1 ± 0.3 |
3.9 ± 0.3 |
3.8 ± 0.4 |
3.8 ± 0.4 |
|
|
FC |
4.7 ± 0.3 |
4.6 ± 0.4 |
4.8 ± 0.3* |
4.8 ± 0.4* |
4.7 ± 0.4* |
4.4 ± 0.4* |
4.3 ± 0.3*§ |
4.1 ± 0.5*§ |
|
|
[Lactate] (mmol·L-1) |
Control |
0.8 ± 0.2 |
3.6 ± 1.9 |
3.4 ± 2.1 |
3.5 ± 2.2 |
3.6 ± 2.1 |
3.8 ± 2.4 |
3.5 ± 1.8 |
4.5 ± 1.8 |
|
F |
0.8 ± 0.3 |
3.4 ± 0.9 |
3.1 ± 1.1 |
3.0 ± 1.3§ |
2.9 ± 1.3§ |
2.9 ± 1.2§ |
3.1 ± 1.2 |
4.1 ± 2.0 |
|
|
FC |
0.8 ± 0.2 |
4.1 ± 1.5* |
4.0 ± 1.8* |
3.9 ± 1.9* |
3.8 ± 1.9* |
3.9 ± 1.9* |
3.9 ± 1.8* |
5.1 ± 2.1* |
|
|
[Pyruvate] (μmol·L-) |
Control |
157 ± 33 |
230 ± 46 |
218 ± 50 |
221 ± 49 |
224 ± 51 |
228 ± 48 |
234 ± 53 |
254 ± 61 |
|
F |
159 ± 33 |
235 ± 49 |
223 ± 58§ |
218 ± 53 |
212 ± 57 |
215 ± 44 |
216 ± 47 |
219 ± 46 |
|
|
FC |
163 ± 41 |
256 ± 52 |
252 ± 58* |
250 ± 57* |
245 ± 57* |
237 ± 63 |
239 ± 61 |
234 ± 51 |
|
|
|
|||||||||
|
Values are presented as the mean ± SD *: Indicates a significant difference from the F trial at the same time-point. §: Indicates a significant difference within the trials compared with the 15 min time-point. |
|||||||||
|
Hadjicharalambous et al. Journal of the International Society of Sports Nutrition 2010 7:22 doi:10.1186/1550-2783-7-22 |
|||||||||